ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
6 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
621
|
219K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
10 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
621
|
219K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
12 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
621
|
219K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
1 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
621
|
219K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
3 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
621
|
219K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
Gan_Gans
|
52 |
20K |
3 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
52
|
20K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
Gan_Gans
|
52 |
20K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
52
|
20K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
Gan_Gans
|
52 |
20K |
7 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
52
|
20K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
Gan_Gans
|
52 |
20K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
52
|
20K
|
4
|
|
ASX - By Stock
|
JMS |
Re:
Ann: Manganese Market Update
|
|
Gan_Gans
|
19 |
8.2K |
7 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
19
|
8.2K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Preliminary Results of 9 Month Toxicology Study of ATL1102
|
|
Gan_Gans
|
37 |
8.6K |
9 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
37
|
8.6K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Gan_Gans
|
4.2K |
3.8M |
2 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Gan_Gans
|
4.2K |
3.8M |
1 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Gan_Gans
|
4.2K |
3.8M |
3 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gan_Gans
|
34 |
18K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
34
|
18K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gan_Gans
|
34 |
18K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
34
|
18K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gan_Gans
|
34 |
18K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
34
|
18K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gan_Gans
|
34 |
18K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
34
|
18K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
621
|
219K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Gan_Gans
|
92 |
39K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
92
|
39K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Gan_Gans
|
92 |
39K |
7 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
92
|
39K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Gan_Gans
|
92 |
39K |
9 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
92
|
39K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
621
|
219K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
621
|
219K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
621
|
219K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Gan_Gans
|
46 |
17K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
46
|
17K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
621
|
219K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
11 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
621
|
219K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
621
|
219K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
621
|
219K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
621
|
219K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
621
|
219K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
621
|
219K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
621
|
219K
|
5
|
|
ASX - By Stock
|
DUB |
Re:
Dubber.Dubber.Do.
|
|
Gan_Gans
|
8.3K |
3.8M |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
8.3K
|
3.8M
|
0
|
|
ASX - By Stock
|
DUB |
Re:
Ann: Appendix 4D and Interim Financial Report 31 Dec 2023
|
|
Gan_Gans
|
27 |
11K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
27
|
11K
|
0
|
|
ASX - By Stock
|
DUB |
Re:
News: DUB Dubber Corp Announces Dismissal Of Managing Director & CEO Steve McGovern
|
|
Gan_Gans
|
179 |
115K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
179
|
115K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
2 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
621
|
219K
|
2
|
|
ASX - By Stock
|
BPT |
Re:
Ann: Waitsia Stage 2 update
|
|
Gan_Gans
|
91 |
39K |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
91
|
39K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Gan_Gans
|
670 |
256K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
670
|
256K
|
1
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Continued Suspension from Quotation
|
|
Gan_Gans
|
347 |
122K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
347
|
122K
|
2
|
|
ASX - By Stock
|
DUB |
Re:
AFR - Cap Raise
|
|
Gan_Gans
|
12 |
5.6K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
12
|
5.6K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
3 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
621
|
219K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
621
|
219K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
621
|
219K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Gan_Gans
|
621 |
219K |
10 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
621
|
219K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 Clinical Trial Update
|
|
Gan_Gans
|
16 |
5.8K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
16
|
5.8K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 Clinical Trial Update
|
|
Gan_Gans
|
16 |
5.8K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
16
|
5.8K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Gan_Gans
|
670 |
256K |
3 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
670
|
256K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Gan_Gans
|
670 |
256K |
6 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
670
|
256K
|
6
|
|